Calamos Advisors’s Argan AGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.91M Sell
6,150
-108
-2% -$71.9K 0.02% 548
2026
Q1
$3.41M Sell
6,258
-6,467
-51% -$2.64M 0.01% 609
2025
Q4
$3.99M Sell
12,725
-14,385
-53% -$4.57M 0.02% 558
2025
Q3
$7.32M Buy
27,110
+3,683
+16% +$844K 0.03% 478
2025
Q2
$5.17M Buy
23,427
+6,748
+40% +$1.22M 0.02% 548
2025
Q1
$2.19M Sell
16,679
-5,364
-24% -$749K 0.01% 585
2024
Q4
$3.02M Sell
22,043
-11,952
-35% -$1.64M 0.01% 567
2024
Q3
$3.45M Buy
33,995
+8,971
+36% +$710K 0.01% 562
2024
Q2
$1.83M Buy
+25,024
New +$1.64M 0.01% 596

Other funds holding AGX

Calamos Advisors's AGX Position: Q2 2026 in Review

Calamos Advisors reduced its Argan (AGX) stake by 1.7% in Q2 2026, selling an estimated $71.9K and leaving 6,150 shares worth $4.91M. The position accounts for 0.02% of the portfolio, ranked #548.

Calamos Advisors first reported a position in AGX in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.32M in Q3 2025. 562 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Calamos Advisors held 6,150 shares of Argan worth $4.91M as of Q2 2026.
  • Calamos Advisors sold 108 Argan shares in Q2 2026, an estimated $71.9K.
  • Argan made up 0.02% of Calamos Advisors's portfolio in Q2 2026, its #548 holding.
  • Calamos Advisors first reported a position in Argan in Q2 2024 and has held it in 9 quarters since.
  • Calamos Advisors's Argan position peaked at $7.32M in Q3 2025.
  • 562 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.